Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulation

Autor: Antoine, Alison, Pérol, David, Robain, Mathieu, Bachelot, Thomas, Choquet, Rémy, Jacot, William, Ben Hadj Yahia, Béchir, Grinda, Thomas, Delaloge, Suzette, Lasset, Christine, Drouet, Youenn

Publikováno v: In European Journal of Cancer December 2024 213

First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort

Autor: Galvin, Angéline, Courtinard, Coralie, Bouteiller, Fanny, Gourgou, Sophie, Dalenc, Florence, Jacot, William, Arnedos, Monica, Bailleux, Caroline, Dieras, Véronique, Petit, Thierry, Emile, George, Dubray-Longeras, Pascale, Frenel, Jean-Sébastien, Bachelot, Thomas, Mailliez, Audrey, Brain, Etienne, Desmoulins, Isabelle, Massard, Vincent, Patsouris, Anne, Goncalves, Anthony, Grinda, Thomas, Delaloge, Suzette, Bellera, Carine

Publikováno v: In European Journal of Cancer January 2024 196

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

Autor: BIDARD, Francois-Clement, PISTILLI, Barbara, DALENC, Florence, BACHELOT, Thomas, DE LA MOTTE ROUGE, Thibault, SABATIER, Renaud, DUBOT, Coraline, FRENEL, Jean-Sébastien, FERRERO, Jean-Marc, LADOIRE, Sylvain, LEVY, Christelle, MOURET-REYNIER, Marie-Ange, HARDY-BESSARD, Anne-Claire, LORTHOLARY, Alain, GRENIER, Julien, CHAKIBA, Camille, STEFANI, Laetitia, SOULIE, Patrick, JACQUIN, Jean-Philippe, PLAZA, Jérôme Edouard, CLATOT, Florian, TEIXEIRA, Luis, D'HONDT, Véronique, VEGAS, Hélène, DERBEL, Olfa, GARNIER TIXIDRE, Claire, DELBALDO, Catherine, MOREAU, Lionel, CHENEAU, Caroline, PAITEL, Jean-François, BERNARD-MARTY, Chantal, SPAETH, Dominique, GENET, Dominique, MOULLET, Isabelle, BONICHON-LAMICHHANE, Nathalie, DEIANA, Laura, GREILSAMER, Charlotte, VENAT-BOUVET, Laurence, DELECROIX, Valérie, MELIS, Adrien, ORFEUVRE, Hubert, NGUYEN, Suzanne, LEGOUFFE, Eric, ZANNETTI, Alain, LE SCODAN, Romuald, DOHOLLOU, Nadine, DALIVOUST, Philippe, ARSENE, Olivier, MARQUES, Nathalie, PETIT, Thierry, MOLLON, Delphine, DAUBA, Jérôme, BONNIN, Nathalie, MORVAN, François, GARDNER, Miriam, MARTI, Adina, LEVACHE, Charles-Briac, LACHAIER, Emma, ACHILLE, Mihaela, VALMAR, Christophe, BOUAITA, Ryan, MEDIONI, Jacques, FOA, Cyril, DEL PIANO, Francesco, GOZY, Michel, ESCANDE, Anne, LEDUC, Nicolas, LUCAS, Brigitte, MILLE, Dominique, AMMARGUELLAT, Hanifa, NAJEM, Abeer, TROUBOUL, Fanny, BARTHELEMY, Philippe, DESCLOS, Hervé, MAYEUR, Didier, LORCHEL, Fabrice, GUINET, François, LAURENTY, Anne-Pascale, BOUDRANT, Axelle, GISSEROT, Olivier, ALLEAUME, Corinne, DE GRAMONT, Aimery, Bidard, François-Clément ^*, Hardy-Bessard, Anne-Claire, Dalenc, Florence, Bachelot, Thomas, Pierga, Jean-Yves, de la Motte Rouge, Thibault, Sabatier, Renaud, Dubot, Coraline, Frenel, Jean-Sébastien, Ferrero, Jean Marc, Ladoire, Sylvain, Levy, Christelle, Mouret-Reynier, Marie-Ange, Lortholary, Alain, Grenier, Julien, Chakiba, Camille, Stefani, Laetitia, Plaza, Jérôme Edouard, Clatot, Florian, Teixeira, Luis, D'Hondt, Véronique, Vegas, Hélène, Derbel, Olfa, Garnier-Tixidre, Claire, Canon, Jean-Luc, Pistilli, Barbara, André, Fabrice, Arnould, Laurent, Pradines, Anne, Bièche, Ivan, Callens, Céline, Lemonnier, Jérôme, Berger, Frédérique, Delaloge, Suzette

Publikováno v: In The Lancet Oncology November 2022 23(11):1367-1377

Validation of prognostic scores for survival in cancer patients beyond first-line therapy

Autor: Quiblier Florent, Saba Chadi, Pérol David, Chabaud Sylvie, Bajard Agathe, Rebattu Paul, Chvetzoff Gisèle, Ray-Coquard Isabelle, Trédan Olivier, Blay Jean-Yves, Bachelot Thomas

Publikováno v: BMC Cancer, Vol 11, Iss 1, p 95 (2011)

Abstract Background We aimed to validate prognostic scores for survival in patients undergoing chemotherapy for advanced or metastatic cancer after first-line treatment. Methods We previously described two models with good prognostic value based on a

Externí odkaz: https://doaj.org/article/89a091cf8be748a6b33a68616aacfcb7

Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer

Autor: Krause Alexander, Paye Malick, Bachelot Thomas, Verjat Thibault, Leissner Philippe, Puisieux Alain, Mougin Bruno

Publikováno v: BMC Cancer, Vol 6, Iss 1, p 216 (2006)

Abstract Background One of the most thoroughly studied systems in relation to its prognostic relevance in patients with breast cancer, is the plasminogen activation system that comprises of, among others, the urokinase Plasminogen Activator (uPA) and

Externí odkaz: https://doaj.org/article/4dd4c4b2714b4f24b0e82e9edca1078f